Tepezza Users Often Require Second Treatment Course for Thyroid Eye Disease
The findings of a new study suggest five percent of Tepezza users require a second treatment course of the thyroid eye disease drug, raising questions as to whether those patients face an even higher risk of hearing loss than other Tepezza users.